HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcony R Santhiago Selected Research

Pathologic Dilatation (Ectasia)

1/2019Validation of the Percent Tissue Altered as a Risk Factor for Ectasia after LASIK.
1/2019Structural relationships in post-refractive surgery ectasia: What have we learned?
1/2019Early Refractive and Clinical Outcomes of High-Myopic Photorefractive Keratectomy as an Alternative to LASIK Surgery in Eyes with High Preoperative Percentage of Tissue Altered.
1/2019Corneal Ectasia Risk And Percentage Tissue Altered In Myopic Patients Presenting For Refractive Surgery.
1/2019Consultation Section: Refractive. Progressive corneal ectasia after LASIK in an eye that already had intrastromal corneal ring segments implantation and corneal crosslinking: June consultation #1.
7/2016Percent tissue altered and corneal ectasia.
1/2016Ectasia risk factors in refractive surgery.
11/2015Relative contribution of flap thickness and ablation depth to the percentage of tissue altered in ectasia after laser in situ keratomileusis.
6/2015Ectasia susceptibility before laser vision correction.
6/2015Accelerated Corneal Collagen Cross-linking for Postoperative LASIK Ectasia: Two-Year Outcomes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcony R Santhiago Research Topics

Disease

15Cataract (Cataracts)
01/2022 - 03/2010
14Pathologic Dilatation (Ectasia)
01/2019 - 01/2012
12Astigmatism
01/2022 - 01/2014
12Keratoconus
01/2022 - 06/2012
9Myopia
01/2021 - 01/2013
8Cicatrix (Scar)
01/2022 - 02/2012
7Fibrosis (Cirrhosis)
01/2022 - 01/2017
5Corneal Injuries
01/2022 - 09/2012
4Wounds and Injuries (Trauma)
01/2022 - 01/2011
4Glaucoma
02/2018 - 01/2011
3Presbyopia
10/2021 - 01/2012
3Keratitis
01/2017 - 02/2012
3Coma (Comas)
09/2014 - 01/2013
3Inflammation (Inflammations)
02/2012 - 01/2011
2Systemic Scleroderma (Systemic Sclerosis)
05/2021 - 02/2018
2Refractive Errors (Refractive Error)
01/2021 - 07/2012
2Hyperopia (Hypermetropia)
01/2017 - 11/2016
2Dry Eye Syndromes (Dry Eye Syndrome)
01/2016 - 08/2014
1Infections
01/2022
1Corneal Diseases (Corneal Disease)
01/2022
1Burns
01/2022
1Hypersensitivity (Allergy)
01/2021
1Ulcer
01/2021
1Photosensitivity Disorders (Photodermatitis)
01/2021
1Nerve Degeneration
11/2020
1Low Vision (Subnormal Vision)
10/2020
1Fuchs' Endothelial Dystrophy
10/2020
1Capsule Opacification
01/2020
1Retrograde Degeneration
12/2018
1Lacerations
10/2017
1Ocular Hypertension (Glaucoma, Suspect)
07/2017
1Corneal Opacity
02/2016
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016
1Neoplasms (Cancer)
01/2016
1Lens Subluxation
05/2015
1Marfan Syndrome (Marfan's Syndrome)
05/2015
1Corneal Ulcer
05/2015

Drug/Important Bio-Agent (IBA)

5CollagenIBA
01/2021 - 06/2012
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2011
3Collagen Type IV (Type IV Collagen)IBA
01/2022 - 12/2021
3Indicators and Reagents (Reagents)IBA
01/2019 - 07/2014
34-hexyloxyaniline (HOA)IBA
09/2014 - 01/2013
2Sodium Hydroxide (Caustic Soda)FDA Link
01/2022 - 01/2011
2perlecanIBA
01/2022 - 01/2021
2Losartan (Cozaar)FDA LinkGeneric
01/2022 - 01/2022
2Transforming Growth Factor beta (TGF-beta)IBA
01/2022 - 02/2016
2Riboflavin (Vitamin B2)FDA LinkGeneric
01/2021 - 06/2012
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 02/2016
2Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2019 - 03/2017
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1InterleukinsIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1prednisolone acetateFDA LinkGeneric
01/2022
1AlkaliesIBA
01/2022
1heparanaseIBA
05/2021
1Capsules (Microcapsules)IBA
05/2021
1Eosine Yellowish-(YS) (Eosin)IBA
05/2021
1CaspasesIBA
05/2021
1Hematoxylin (Haematoxylon)IBA
05/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Singlet OxygenIBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1AntigensIBA
01/2021
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Antiglaucoma AgentsIBA
07/2017
1Ophthalmic Solutions (Eye Drops)IBA
07/2017
1Tobramycin (Nebcin)FDA LinkGeneric
01/2017
1Interleukin-1 (Interleukin 1)IBA
02/2016
1CytokinesIBA
02/2016
1AnticoagulantsIBA
05/2015
1Warfarin (Coumadin)FDA LinkGeneric
05/2015

Therapy/Procedure

21Laser In Situ Keratomileusis (LASIK)
01/2019 - 07/2012
12Refractive Surgical Procedures
01/2021 - 01/2012
9Photorefractive Keratectomy
01/2022 - 09/2012
9Intraocular Lenses (Intraocular Lens)
10/2021 - 03/2010
7Lasers (Laser)
01/2022 - 02/2012
6Excimer Lasers
01/2021 - 08/2015
4Corneal Transplantation (Keratoplasty)
01/2022 - 12/2016
4Phacoemulsification
01/2022 - 05/2015
4Multifocal Intraocular Lenses
10/2021 - 11/2010
4Corneal Cross-Linking
02/2019 - 06/2015
3Therapeutics
05/2015 - 08/2014
2Contact Lenses
01/2022 - 08/2014
2Penetrating Keratoplasty
01/2021 - 10/2017
2Keratectomy
03/2017 - 09/2012
2Intraocular Lens Implantation
01/2016 - 03/2010
1Duration of Therapy
01/2022
1Lenses
10/2021
1Posterior Capsulotomy
01/2019
1Laser-Assisted Subepithelial Keratectomy (LASEK)
01/2019
1Vitrectomy
01/2019
1Operative Time
10/2018
1Radial Keratotomy
10/2017
1Debridement
03/2017
1Slit Lamp
01/2017
1Cataract Extraction
01/2016
1Anesthesia
05/2015